COVID-19 pandemic impact on telehealth use and perceptions for atopic and respiratory disease: Survey results
Don A. Bukstein(Institute for Asthma and Allergy), Tonya Winders, Jacqueline Eghrari-Sabet, Tanisha Hill(Teva Pharmaceuticals (United States)), Mary Hart, Purvi Parikh(New York University)
Cited by 11
Related Papers
The economic impact of allergic rhinitis and current guidelines for treatment
|Annals of Allergy Asthma & Immunology|2011|268
Shared decision making for the allergist
|Annals of Allergy Asthma & Immunology|2018|119
The Challenges and Opportunities for Shared Decision Making Highlighted by COVID-19
|The Journal of Allergy and Clinical Immunology In Practice|2020|119
Digital Health Technology in Asthma: A Comprehensive Scoping Review
|The Journal of Allergy and Clinical Immunology In Practice|2021|119
Evaluation of a short form for measuring health-related quality of life among pediatric asthma patients
|Journal of Allergy and Clinical Immunology|2000|93